Monday's WorkCompCentral arrived with William Rabb’s report on the use of opioids by workers’ comp patients in Louisiana.
A few notable findings:
For some reason, some “claimants' attorneys” don’t see the wisdom of formularies/guidelines intended to reduce inappropriate opioid use, citing spurious claims from the pain industry in an attempt to validate their complaints.
Louisiana has had treatment guidelines in place for several years. However, they have not been revised or updated in memory and are very difficult to enforce. Compared to other states, the Pelican State has made little progress reducing inappropriate opioid use by work comp patients.
Back in 2017, I cited Sheral Kellar, director of Louisiana’s Office of Workers’ Compensation Administration, discussing the opioid issue in her state. Kellar knows a formulary is NOT a panacea, but rather a critical tool in the armamentarium which includes:
Over the last decade I have spoken with many individuals heavily involved in Louisiana workers’ comp, each frustrated and saddened by the lack of meaningful progress in attacking the overuse of opioids by workers’ comp patients.
What does this mean for you?
Here’s hoping Louisiana is able to make real progress on reducing opioid usage. Families, communities, employers and providers have all waited long enough.
Joseph Paduda is co-owner of CompPharma, a consulting firm focused on improving pharmacy programs in workers’ compensation. This column is republished with his permission from his Managed Care Matters blog.
Jan 23-26, 2020
Join us in Rancho Mirage for CAAA's 2020 Winter Convention! For more details about the event, cl …
Feb 8, 2020
Please join us in honoring leading ladies and gentlemen of the insurance industry. Walk the Red C …
Feb 25, 2020
Registration: 7:30am | Shotgun Start: 9am Location: Del Monte Golf Course All proceeds go to the …